GS0051: Chemical compounds and compositions for use in pharmaceutical preparations and kits
GS0421: Developing and providing chemical compounds and compositions for the detection of apoptosis and inflammation for diagnosticDeveloping and providing chemical compounds and compositions for the detection of apoptosis and inflammation for diagnostic, clinical, medical, and research purposes, including assessment and monitoring of various diseases related to apoptosis (e.g., cancers, eye diseases, cardiovascular diseases, neurodegenerative diseases, autophagy) and inflammation and assessment of efficacy of therapeutic treatments intended to induce apoptosis, clinical, medical, and research purposes, including assessment and monitoring of various diseases related to apoptosis (e.g., cancers, eye diseases, cardiovascular diseases, neurodegenerative diseases, autophagy) and inflammation and assessment of efficacy of therapeutic treatments intended to induce apoptosis